Photodynamic Therapy in Cancer—Second Edition

Dear Colleagues,

Photodynamic therapy (PDT) is clinically approved for the treatment of various cancer and non-cancer applications. It exerts direct efficacy in destroying primary tumors, utilizing a light-activatable molecule—termed a photosensitizer—with light of an appropriate wavelength, along with oxygen, in order to impart cytotoxicity via the generation of reactive molecular species. In addition to therapeutic effects, photosensitizer-mediated fluorescence can also be used for image-guided surgery. Benefiting from the rapid development of nanotechnology, sophisticated targeting approaches, and the emergence of nanocarriers for the codelivery of multiple therapeutics, PDT in combination with chemotherapy, photothermal therapy, radiotherapy, and immunotherapy can significantly enhance treatment outcomes, minimizing the off-target effects.

This Special Issue, entitled “Photodynamic Therapy of Cancer”, aims to publish the latest research and translational work in the field of PDT in the form of original articles relating to nanodelivery carriers, photochemical and photobiological aspects, targeted drug delivery, tumor image-guided surgery, immunogenic cell death, and PDT-based multimodal therapies of cancer.

Dr. Shazia Bano
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.